ゾラゼパムおよびチレタミン

使用用途

• General anaesthesia
• General anaesthesia
• General anaesthesia
• General anaesthesia

投与方法

考えられる副作用

• Excessive salivation (ptyalism)
• Muscle rigidity during recovery
• Prolonged and excitable recovery (especially in dogs at higher doses)
• Pain on intramuscular injection (particularly in cats)
• Respiratory depression (can be fatal in neonates)
• Hypothermia

注意事項と禁忌

• Severe cardiac disease
• Severe respiratory disease
• Hypertensive disease
• Renal insufficiency
• Pancreatic insufficiency
• Hepatic insufficiency
• Head trauma or intracranial tumours
• Pregnancy (crosses the placenta and causes fatal respiratory depression in neonates)
• > **Human Safety Warning:** Pregnant women should avoid handling the product. * **Recovery Environment:** Following anesthesia, return to normal is progressive (2-6 hours). Animals must be kept in a calm, quiet environment. Avoid excessive noise and light. * **Patient Factors:** Recovery may be significantly delayed in obese, old, or debilitated animals. * **Parasite Collars:** Remove any antiparasitic collar 24 hours before anesthesia. * **Secretions:** Excessive salivation can occur; consider administration of an anticholinergic (e.g., atropine or glycopyrrolate) to control this.

薬物相互作用

• Phenothiazines (e.g., Acepromazine): Increased cardiorespiratory depression and increased hypothermic effect during the last phase of anesthesia.
• Chloramphenicol: Slows down the elimination of the anesthetics if used during the pre- or intraoperative period.

よくある質問